World tuberculosis day 2014
This presentation is the property of its rightful owner.
Sponsored Links
1 / 17

World Tuberculosis Day 2014 PowerPoint PPT Presentation


  • 66 Views
  • Uploaded on
  • Presentation posted in: General

World Tuberculosis Day 2014. The TB situation in 2012 : Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe . ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2014.

Download Presentation

World Tuberculosis Day 2014

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


World tuberculosis day 2014

World Tuberculosis Day 2014

The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe

ECDC TB TeamEuropean Centre for Disease Prevention and Control

Stockholm, 24 March 2014


Monitoring four epidemiological indicators eight core indicators

MonitoringFour epidemiological indicatorsEight core indicators


Epidemiological indicators

Epidemiological indicators


Indicator 1 trends in case notification rate 2008 2012

Indicator 1: Trends in case notification rate 2008−2012

  • Target: Mean declining trend over the previous five years

  • Status 2012: 21 countries met the target

Figure 1: Trend in TB notification rate, EU/EEA, 2008−2012


Indicator 2 trends in multidrug resistant tb case notification rate

Indicator 2: Trends in multidrug-resistant TB case notification rate

  • Target: Mean declining trend in MDR TB over the previous five years

  • Status 2012:7countries met the target

Figure 2: Multidrug-resistant TB notification rate per 100 000 by year, EU/EEA, 2008−2012


Indicator 3 trends in child to adult notification ratio

Indicator 3: Trends in child-to-adult notification ratio

  • Target: Mean declining 10-year trend in child-to-adult notification ratio

  • Status 2012: Three countries reported a declining trend

Figure 3: Child-to-adult TB notification ratio, EU/EEA, 2003−2012


Indicator 4 trends in mean age of tb cases

Indicator 4: Trends in mean age of TB cases

  • Target: Increasing 10-year trend

  • Status 2012: Twelve countries met the target

Figure 4: Trend in mean age of TB cases, EU/EEA, 2003−2012


Core indicators

Core indicators


Indicator 1 and 2 availability of national tb control plan and implementation guidelines

Indicator 1 and 2: Availability of national TB control plan and implementation guidelines

  • Figure 5: Availability of a national TB control plan and implementation guidelines, EU/EEA, 2012

National TB control plan available with implementation guidelines

National TB control plan available

National TB control plan not available

Information not available or country not reporting

  • 13 countries have a national TB control plan

  • 11 countries have a plan and guidelines for implementation


World tuberculosis day 2014

Indicator 3: Percentage of national TB reference laboratories achieving adequate performance in the external quality assessment (EQA) scheme

Target: 100% of national TB reference laboratories achieving ≥ 80% performance (smear, culture, first- and second-line drug susceptibility testing).

Status 2012*: Nineteen laboratories participated in the EQA for all four diagnostic methods and 18 (95%) laboratories achieved a performance of ≥ 80% for all four methods.

* Results for 2012 report obtained from European Reference Laboratory Network for Tuberculosis (ERLN-TB) for smear microscopy, culture, and drug susceptibility testing for first- and second-line TB drugs. No country-specific data are available.


Indicator 4 availability of a strategy for introducing and implementing new tools for tb control

Indicator 4: Availability of a strategy for introducing and implementing new tools for TB control

Target: All Member States (100%) have a strategy within the national TB programme supporting the introduction and implementation of new tools for TB control.

Status 2012: Seven countries have a strategy in place.

  • Figure 6: Availability of a strategy for introducing and implementing new tools for TB control, by country, EU/EEA, 2012

Strategy for new tools for TB control available

Strategy for new tools for TB control not available

Information not available or country not reporting


Indicator 5 percentage of new pulmonary tb cases confirmed by culture

Indicator 5: Percentage of new pulmonary TB cases confirmed by culture

  • Target: 80% of new pulmonary TB cases are culture confirmed.

  • Status 2012: 69.8% of new pulmonary TB cases were culture confirmed, 11 countries met the target.

Figure 7: Percentage of new pulmonary TB cases confirmed by culture by country, EU/EEA, 2012


Indicator 5 percentage of new pulmonary tb cases tested by dst for first line drugs

Indicator 5: Percentage of new pulmonary TB cases tested by DST for first-line drugs

Target: 100% of TB cases tested for susceptibility to first-line drugs (isoniazid and rifampicin) among new pulmonary TB cases.

Status 2012: For 77.6% of culture-confirmed TB cases, DST results for first line drugs were reported; seven countries met the 100% target.

  • Figure 8: Percentage of new pulmonary TB cases tested for susceptibility to first line drugs, by country, EU/EEA, 2012

< 50%

50 to 84.9%

85 to 99.9%

100%

Not included or not reporting


Indicator 6 percentage of member states reporting treatment success rate

Indicator 6: Percentage of Member States reporting treatment success rate

Target: All Member States (100%) report treatment outcome monitoring to ECDC.

Status 2012: 26 EU/EEA Member

States reported treatment outcome

for new culture-confirmed pulmonary

TB cases notified in 2011.

  • Figure 9: Treatment outcome reporting for new pulmonary TB cases notified in 2011, by country, EU/EEA, 2012

Treatment outcome reported

Treatment outcome not reported


Indicator 7 treatment success rate

Indicator 7: Treatment success rate

  • Target: Treatment success rate of at least 85% for new pulmonary culture-confirmed TB cases.

  • Status 2012: Treatment success rate for EU/EEA was 76.5% (range: 0–91.3%), targetmet by three countries.

Figure 10: Treatment success rate in culture-confirmed new pulmonary TB cases notified in 2011, by country, EU/EEA, 2012

* Iceland and Malta reported zero new TB cases in 2011. Three EU/EEA Member States did not report treatment outcome data


Indicator 7 treatment success rate new pulmonary culture positive mdr tb cases

Indicator 7: Treatment success rate new pulmonary culture positive MDR TB cases*

  • Target: Treatment success of 70% of new pulmonary culture-positive MDR TB cases

  • Status 2012: Success rate in EU/EEA was 47.6% (range 0–100.0%), targetmet by 4 countries

Figure 11: 24-month treatment success rate in new pulmonary culture positive multidrug-resistant TB cases notified in 2010, by country, EU/EEA, 2012

* Cyprus, Iceland, Malta, Slovakiaand Slovenia reported zero MDR TB cases in 2010, seven Member States did not report stratified treatment outcome data


Indicator 8 percentage of tb patients for whom hiv status is known

Indicator 8: Percentage of TB patients for whom HIV status is known

Figure 12: Percentage of TB cases with HIV status reported, by country, EU/EEA, 2012

< 50%

50 to 74.9%

75 to 99.9%

100%

Not included or not reporting

Target: HIV status is known for 100% of notified TB cases.

Status 2012: 16 countries (60.6%) reported HIV test results, one country met the 100% target.


  • Login